Jesse W. Keller

1.4k total citations · 1 hit paper
15 papers, 1.0k citations indexed

About

Jesse W. Keller is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Jesse W. Keller has authored 15 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 3 papers in Surgery. Recurrent topics in Jesse W. Keller's work include Cancer Immunotherapy and Biomarkers (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers) and Acute Lymphoblastic Leukemia research (3 papers). Jesse W. Keller is often cited by papers focused on Cancer Immunotherapy and Biomarkers (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers) and Acute Lymphoblastic Leukemia research (3 papers). Jesse W. Keller collaborates with scholars based in United States and Japan. Jesse W. Keller's co-authors include Christine A. Iacobuzio–Donahue, Manuel Hidalgo, Alison P. Klein, Daniel A. Laheru, Ralph H. Hruban, Shinichi Yachida, F Vilardell, James R. Eshleman, Baojin Fu and Marc K. Halushka and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Jesse W. Keller

14 papers receiving 1.0k citations

Hit Papers

DPC4 Gene Status of the Primary Carcinoma Correlates With... 2009 2026 2014 2020 2009 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jesse W. Keller United States 8 857 372 357 222 218 15 1.0k
Antonio Cubillo Spain 18 864 1.0× 253 0.7× 233 0.7× 208 0.9× 248 1.1× 88 1.1k
Michael J. Swartz United States 12 975 1.1× 321 0.9× 283 0.8× 381 1.7× 410 1.9× 13 1.2k
Tina E. Wood United States 7 900 1.1× 218 0.6× 331 0.9× 266 1.2× 173 0.8× 12 1.1k
Zishuo I. Hu United States 11 748 0.9× 378 1.0× 415 1.2× 217 1.0× 225 1.0× 12 1.2k
Mei‐Kim Ang Singapore 19 658 0.8× 473 1.3× 372 1.0× 372 1.7× 319 1.5× 64 1.3k
Matthew D. Callister United States 10 785 0.9× 321 0.9× 225 0.6× 301 1.4× 269 1.2× 20 1.0k
Avani Satish Dholakia United States 10 806 0.9× 375 1.0× 290 0.8× 52 0.2× 172 0.8× 25 952
N. Pavlidis Greece 14 894 1.0× 442 1.2× 736 2.1× 191 0.9× 238 1.1× 38 1.5k
Max M. Wattenberg United States 14 843 1.0× 251 0.7× 250 0.7× 240 1.1× 75 0.3× 25 1.2k
Maria Chiara Tronconi Italy 17 1.1k 1.2× 370 1.0× 177 0.5× 147 0.7× 704 3.2× 44 1.4k

Countries citing papers authored by Jesse W. Keller

Since Specialization
Citations

This map shows the geographic impact of Jesse W. Keller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesse W. Keller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesse W. Keller more than expected).

Fields of papers citing papers by Jesse W. Keller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jesse W. Keller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesse W. Keller. The network helps show where Jesse W. Keller may publish in the future.

Co-authorship network of co-authors of Jesse W. Keller

This figure shows the co-authorship network connecting the top 25 collaborators of Jesse W. Keller. A scholar is included among the top collaborators of Jesse W. Keller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jesse W. Keller. Jesse W. Keller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Thomas, Theodore, et al.. (2023). A real-world study of pneumonitis in non-small cell lung cancer patients receiving durvalumab following concurrent chemoradiation. Journal of Thoracic Disease. 15(12). 6427–6435. 7 indexed citations
2.
Chin, R, Christopher Abraham, Clifford G. Robinson, et al.. (2021). Brain Metastases in Metastatic Cutaneous Melanoma: Patterns of Care and Clinical Outcomes in the Era of Immunotherapy and Targeted Therapy. International Journal of Radiation Oncology*Biology*Physics. 111(3). e565–e566. 1 indexed citations
3.
Thomas, Theodore, Suhong Luo, E Knoche, Kristen M. Sanfilippo, & Jesse W. Keller. (2020). Evaluation of the incidence of pneumonitis in United States veterans with non-small cell lung cancer receiving durvalumab following chemoradiation.. Journal of Clinical Oncology. 38(15_suppl). 9034–9034. 6 indexed citations
4.
Thomas, Theodore, Suhong Luo, Patrick M. Reagan, et al.. (2019). Advancing age and the risk of bleomycin pulmonary toxicity in a largely older cohort of patients with newly diagnosed Hodgkin Lymphoma. Journal of Geriatric Oncology. 11(1). 69–74. 14 indexed citations
5.
Gabani, Prashant, Benjamin W. Fischer‐Valuck, Tanner M. Johanns, et al.. (2018). Stereotactic radiosurgery and immunotherapy in melanoma brain metastases: Patterns of care and treatment outcomes. Radiotherapy and Oncology. 128(2). 266–273. 44 indexed citations
6.
Sanfilippo, Kristen M., Tzu‐Fei Wang, Suhong Luo, et al.. (2018). Predictive ability of the khorana score for venous thromboembolism (VTE) in multiple myeloma (MM).. Journal of Clinical Oncology. 36(15_suppl). e18733–e18733. 8 indexed citations
7.
Trikalinos, Nikolaos A., Amy Zhou, Maria B. Majella Doyle, et al.. (2018). Systemic Therapy for Combined Hepatocellular-Cholangiocarcinoma: A Single-Institution Experience. Journal of the National Comprehensive Cancer Network. 16(10). 1193–1199. 46 indexed citations
8.
Sanfilippo, Kristen M., Suhong Luo, Tzu‐Fei Wang, et al.. (2018). Predicting Risk of Venous Thromboembolism in Multiple Myeloma: The Impede VTE Score. Blood. 132(Supplement 1). 141–141. 2 indexed citations
9.
Thomas, Theodore, Bindiya Patel, Suhong Luo, et al.. (2018). Impact of metformin use on pathologic response following chemoradiotherapy in rectal cancer.. Journal of Clinical Oncology. 36(15_suppl). e15642–e15642.
10.
Keller, Jesse W., Charalambos Andreadis, Lloyd E. Damon, et al.. (2014). Hematopoietic cell transplantation comorbidity index (HCT-CI) is predictive of adverse events and overall survival in older allogeneic transplant recipients. Journal of Geriatric Oncology. 5(3). 238–244. 10 indexed citations
11.
Keller, Jesse W., et al.. (2014). Analysis of the genomic profile of biphenotypic tumors compared to cholangiocarcinoma and hepatocellular carcinoma.. Journal of Clinical Oncology. 32(3_suppl). 226–226. 4 indexed citations
12.
Keller, Jesse W., Lloyd E. Damon, Lawrence D. Kaplan, et al.. (2013). Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) Is Predictive of Serious Adverse Events and Overall Survival in Older Allogeneic Transplant Recipients. Biology of Blood and Marrow Transplantation. 19(2). S293–S294. 1 indexed citations
13.
Yoshimura, Kiyoshi, Kristen F. Meckel, Christina Y. Chia, et al.. (2009). Integrin α2 Mediates Selective Metastasis to the Liver. Cancer Research. 69(18). 7320–7328. 69 indexed citations
14.
Iacobuzio–Donahue, Christine A., Baojin Fu, Shinichi Yachida, et al.. (2009). DPC4 Gene Status of the Primary Carcinoma Correlates With Patterns of Failure in Patients With Pancreatic Cancer. Journal of Clinical Oncology. 27(11). 1806–1813. 799 indexed citations breakdown →
15.
Tsujino, Kayoko, et al.. (1995). Definitive radiation therapy for extrahepatic bile duct carcinoma.. Radiology. 196(1). 275–280. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026